Value Creation in an Expansion-Phase Bio-Manufacturing Firm: Evidence from EVA at Huaheng Bio (20202024)
Abstract
publicly disclosed annual reports for 20202024. EVA is measured as after-tax operating profit net of a capital charge, with the cost of capital
estimated through a consistent WACC procedure. The results show a clear turning point: EVA remains positive through 2023 but turns negative in 2024, indicating that operating profit realization failed to cover the opportunity cost of the enlarged invested-capital base. Decomposition suggests the reversal is jointly driven by a sharp decline in profit realization and a higher capital charge associated with rapid capitalbase growth. The findings imply that expansion can compress value creation when capital-to-profit conversion lags, highlighting the need for
disciplined capital allocation and stronger liquidity resilience during the conversion period.
Keywords
Full Text:
PDFReferences
[1] Huang J, Mei Z, Li Z. Business and financial information integration and voluntary management earnings forecasts[J]. China Journal of
Accounting Research, 2020, 13(3): 291-307.
[2] Gao J. Research on financial informatization construction of business and finance integration[J]. International Journal of Science and
Research (IJSR), 2022, 11(7): 354-358.
[3] Chen Y, Jin Z, Qin B. Economic Value Added in performance measurement: A simulation approach and empirical evidence[J]. Accounting & Finance, 2023, 63(1): 109-140.
[4] Tripathi P M, Chotia V, Solanki U, et al. Economic value added research: Mapping thematic structure and research trends[J]. Risks,
2022, 11(1): 9.
DOI: http://dx.doi.org/10.70711/memf.v3i3.8852
Refbacks
- There are currently no refbacks.